Please assess the completion status of the following clinical trial:

Trial Title: SMaRT Blood: Single-unit Versus Multiple-unit Packed Red Blood Cell Transfusion in Non-acute Postpartum Anemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women over 18~* Willing and stable to give consent~* \> 6 hours postpartum from any mode of delivery~* Determined by their physician to require blood transfusion either by:~  * Hb \<7g/dL OR~ * \>7g/dL with any sign or symptom of anemia such as fatigue, dizziness, tachycardia, or hypotension~* Agreed to accept blood transfusion~* No contraindications to blood transfusion~Exclusion Criteria:~* hemoglobinopathies~* patients with an ejection fraction \<35%~* Hb \<5 g/dL~* HR \> 130 bpm, BP \< 80/40

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Single-Unit Blood Transfusion Protocol (Type: ACTIVE_COMPARATOR): In this arm, patients receive a 1 unit pRBC transfusion with the plan for post-transfusion blood count at 4-6 hours post-transfusion and clinical reassessment.
- Multiple-Unit Blood Transfusion Protocol (Type: ACTIVE_COMPARATOR): In this arm, patients receive 2 units of pRBCs, followed by 4-6 hour post-transfusion blood count and clinical reassessment.

Based on this trial design, predict the completion outcome and termination type (if applicable).